Randomized double-blind comparison of the safety and efficacy of novel once daily and conventional twice daily formulation of ciprofloxacin in uncomplicated urinary tract infection

被引：2
|
作者：
Berner, B
Cramer, M
Park, M
Chiang, YK
Louie-Helm, J
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)37357-9
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial
    Guenther, L
    Cambazard, F
    Van de Kerkhof, PCM
    Snellman, E
    Kragballe, K
    Chu, AC
    Tegner, E
    Garcia-Diez, A
    Springborg, J
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) : 316 - 323
  • [22] Once-daily fleroxacin versus twice-daily ciprofloxacin in treatment of complicated urinary tract infections.
    Frankenschmidt, A
    Naber, KG
    Bischoff, W
    Kullmann, K
    JOURNAL OF UROLOGY, 1997, 158 (04): : 1494 - 1499
  • [23] A DOUBLE-BLIND COMPARISON OF THE EFFICACY AND SAFETY OF KETOPROFEN EXTENDED-RELEASE (200 MG ONCE-DAILY) AND DICLOFENAC (75 MG TWICE-DAILY) FOR TREATMENT OF OSTEOARTHRITIS
    KENNEDY, AC
    MULLEN, BJ
    ROTH, SH
    GERMAIN, BF
    BONEBRAKE, RA
    WEI, N
    WILLKENS, RF
    LAWSON, JG
    APPELROUTH, DJ
    WHITE, RE
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1994, 55 (02): : 119 - 132
  • [24] Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis
    Talan, DA
    Klimberg, IW
    Nicolle, LE
    Song, J
    Kowalsky, SF
    Church, DA
    JOURNAL OF UROLOGY, 2004, 171 (02): : 734 - 739
  • [25] A DOUBLE-BLIND MULTICENTER STUDY OF SULINDAC ONCE DAILY VERSUS SULINDAC TWICE DAILY IN OSTEOARTHRITIS OF THE KNEE
    CHUBICK, A
    WORLEY, WE
    BERMAN, RS
    DOBRINSKA, MR
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 41 (05): : 692 - 705
  • [26] A MULTICENTER DOUBLE-BLIND-STUDY OF THE EFFICACY AND SAFETY OF ONCE AND TWICE DAILY DILEVALOL COMPARED TO PROPRANOLOL
    SCHOENBERGER, JA
    WALLIN, JD
    GORWIT, JI
    DAVIDOV, ME
    MICHELSON, EL
    POLAND, MP
    FRISHMAN, WH
    AMERICAN JOURNAL OF HYPERTENSION, 1989, 2 (11) : 840 - 846
  • [27] SAFETY AND EFFICACY OF 8MG ONCE-DAILY VERSUS 4MG TWICE-DAILY SILODOSIN WITH LOWER URINARY TRACT SYMPTOMS SUGGESTIVE OF BPH; 12-WEEK, DOUBLE-BLIND, RANDOMIZED, COMPARISON, MULTI-CENTER STUDY
    Song, Miho
    Chun, Jiyoun
    Han, Ji-Yeon
    Park, Won Hee
    Paick, Jae-Seung
    Lee, Kyu-Sung
    Choo, Myung-Soo
    Kim, Joon Chul
    Choi, Jong Bo
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (02) : 161 - 161
  • [28] A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis
    Cox, CE
    Marbury, TC
    Pittman, WG
    Brown, GL
    Auerbach, SM
    Fox, BC
    Yang, JY
    CLINICAL THERAPEUTICS, 2002, 24 (02) : 223 - 236
  • [29] A DOUBLE-BLIND MULTICENTER STUDY OF SULINDAC ONCE DAILY VERSUS SULINDAC TWICE DAILY IN RHEUMATOID-ARTHRITIS
    MCILWAIN, HH
    WORLEY, WE
    BERMAN, RS
    DOBRINSKA, MR
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 41 (05): : 679 - 691
  • [30] Once-daily versus twice-daily vigabatrin:: Is there a difference?: The results of a double-blind pilot study
    Zahner, B
    Stefan, H
    Blankenhorn, V
    Krämer, G
    Richens, A
    Thümler, R
    Mumford, JP
    EPILEPSIA, 1999, 40 (03) : 311 - 315
12345